What this means
This study is a clinical trial that is still recruiting people. It has not posted any results yet, so we do not know if frailty checks work.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 60 and over
- Where
- 1 site, including Pennsylvania
The science
- Registered title
- Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
- Trial ID
- NCT03680677 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Leukemia, Acute, MDS
- What is tested
- Bone Marrow or Peripheral Blood Graft (BMT), Cancer-directed Therapy or Best Supportive Care, Frailty Assessment
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Ages
- 60 Years to no maximum
- Dates
- First posted Sep 21, 2018 · updated Aug 12, 2026
Registry summary
The purpose of this research study is to determine if frailty assessments can be used to predict how well patients aged 60 years and older will do after chemotherapy, CAR T-cell therapy, or allogeneic stem cell transplant.
Sites (1)
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States